ArticleJournal of Cancer2017

ERCC1_202 Is A Prognostic Biomarker in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.

Xiyong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.